470 related articles for article (PubMed ID: 16552337)
21. A comparative analysis of pancreas cyst fluid CEA and histology with DNA mutational analysis in the detection of mucin producing or malignant cysts.
Sreenarasimhaiah J; Lara LF; Jazrawi SF; Barnett CC; Tang SJ
JOP; 2009 Mar; 10(2):163-8. PubMed ID: 19287110
[TBL] [Abstract][Full Text] [Related]
22. Detection of K-ras mutations by denaturing gradient gel electrophoresis (DGGE): a study on pancreatic cancer.
Pellegata NS; Losekoot M; Fodde R; Pugliese V; Saccomanno S; Renault B; Bernini LF; Ranzani GN
Anticancer Res; 1992; 12(5):1731-5. PubMed ID: 1444240
[TBL] [Abstract][Full Text] [Related]
23. [Sensitive detection of K-ras oncogene codon 12 mutations by nested PCR using mismatched primers and selective digestion of non-mutated PCR fragments with restriction enzyme].
Fukayama N; Sugano K; Kyogoku A; Nose H; Kondou H; Ohkura H
Rinsho Byori; 1993 Sep; 41(9):1017-23. PubMed ID: 8254964
[TBL] [Abstract][Full Text] [Related]
24. Patterns of K-ras codon 12 and 13 mutations found in pancreatic adenocarcinoma of 30 Chinese patients by microdissection, PCR and direct sequencing.
Wei S; Liang Z; Gao J; Wu S; Zhu H; Liu H; Liu T
J Gastroenterol Hepatol; 2005 Jan; 20(1):67-72. PubMed ID: 15610449
[TBL] [Abstract][Full Text] [Related]
25. Analysis of K-ras mutations in pancreatic tissue after fine needle aspirates.
Pabst B; Arps S; Binmoeller K; Thul R; Walsemann G; Fenner C; Klapdor R
Anticancer Res; 1999; 19(4A):2481-3. PubMed ID: 10470178
[TBL] [Abstract][Full Text] [Related]
26. [Ki-ras mutation as a molecular tumor marker for carcinoma of the pancreas].
Daus H; Trümper L; Bürger B; Jacobs G; Kriener S; von Blohn G; Zeitz M; Pfreundschuh M
Dtsch Med Wochenschr; 1995 Jun; 120(23):821-5. PubMed ID: 7781522
[TBL] [Abstract][Full Text] [Related]
27. Detection of APC and k-ras mutations in the serum of patients with colorectal cancer.
Lauschke H; Caspari R; Friedl W; Schwarz B; Mathiak M; Propping P; Hirner A
Cancer Detect Prev; 2001; 25(1):55-61. PubMed ID: 11270422
[TBL] [Abstract][Full Text] [Related]
28. K-ras mutation: early detection in molecular diagnosis and risk assessment of colorectal, pancreas, and lung cancers--a review.
Minamoto T; Mai M; Ronai Z
Cancer Detect Prev; 2000; 24(1):1-12. PubMed ID: 10757118
[TBL] [Abstract][Full Text] [Related]
29. Common occurrence of multiple K-RAS mutations in pancreatic cancers with associated precursor lesions and in biliary cancers.
Laghi L; Orbetegli O; Bianchi P; Zerbi A; Di Carlo V; Boland CR; Malesci A
Oncogene; 2002 Jun; 21(27):4301-6. PubMed ID: 12082617
[TBL] [Abstract][Full Text] [Related]
30. [Detection of micrometastases after curative resection for ductal adenocarcinoma of the pancreas].
Niedergethmann M; Rexin M; Knob S; Hartel M; Sturm JW; Richter A; Post S
Zentralbl Chir; 2001 Nov; 126(11):917-21. PubMed ID: 11753804
[TBL] [Abstract][Full Text] [Related]
31. [An application value of detecting K-ras and p53 gene mutation in the stool and pure pancreatic juice for diagnosis of early pancreatic cancer].
Lu X; Xu T; Qian J
Zhonghua Yi Xue Za Zhi; 2001 Sep; 81(17):1050-3. PubMed ID: 11758254
[TBL] [Abstract][Full Text] [Related]
32. Detection of K-ras gene mutation at codon 12 by pancreatic duct brushing for pancreatic cancer.
Liu F; Li ZS; Xu GM; Sun ZX; Zhou GX; Ren XX; Tu ZX; Gong YF
Hepatobiliary Pancreat Dis Int; 2003 May; 2(2):313-7. PubMed ID: 14599992
[TBL] [Abstract][Full Text] [Related]
33. Assay design and optimization of mutant-enriched PCR based method for detection of K-ras gene mutations in pancreatic carcinoma.
Ugorcáková J; Hlavatý T; Babál P; Janega P; Bukovská G; Halgasová N; Hlavatá A; Timko J; Duris I
Neoplasma; 2006; 53(5):363-71. PubMed ID: 17013530
[TBL] [Abstract][Full Text] [Related]
34. K-ras mutations in duodenal aspirate without secretin stimulation for screening of pancreatic and biliary tract carcinoma.
Watanabe H; Ha A; Hu YX; Ohtsubo K; Yamaguchi Y; Motoo Y; Okai T; Toya D; Tanaka N; Sawabu N
Cancer; 1999 Oct; 86(8):1441-8. PubMed ID: 10526271
[TBL] [Abstract][Full Text] [Related]
35. Detection of mutated c-Ki-ras in the bile of patients with pancreatic cancer.
Abbruzzese JL; Evans DB; Raijman I; Larry L; King T; Leach SD; Frazier ML
Anticancer Res; 1997; 17(2A):795-801. PubMed ID: 9137410
[TBL] [Abstract][Full Text] [Related]
36. K-ras mutation in focal proliferative lesions of human pancreas.
Terhune PG; Phifer DM; Tosteson TD; Longnecker DS
Cancer Epidemiol Biomarkers Prev; 1998 Jun; 7(6):515-21. PubMed ID: 9641496
[TBL] [Abstract][Full Text] [Related]
37. K-ras codon 12 and 13 mutations are correlated with differential patterns of tumor cell dissemination in colorectal cancer patients.
Conzelmann M; Linnemann U; Berger MR
Int J Oncol; 2004 Jun; 24(6):1537-44. PubMed ID: 15138598
[TBL] [Abstract][Full Text] [Related]
38. Clinical significance of cathepsin E in pancreatic juice in the diagnosis of pancreatic ductal adenocarcinoma.
Uno K; Azuma T; Nakajima M; Yasuda K; Hayakumo T; Mukai H; Sakai T; Kawai K
J Gastroenterol Hepatol; 2000 Nov; 15(11):1333-8. PubMed ID: 11129230
[TBL] [Abstract][Full Text] [Related]
39. Detection of c-K-ras mutations in fine needle aspirates from human pancreatic adenocarcinomas.
Shibata D; Almoguera C; Forrester K; Dunitz J; Martin SE; Cosgrove MM; Perucho M; Arnheim N
Cancer Res; 1990 Feb; 50(4):1279-83. PubMed ID: 2404591
[TBL] [Abstract][Full Text] [Related]
40. Increased K-ras mutation and expression of S100A4 and MUC2 protein in the malignant intraductal papillary mucinous tumor of the pancreas.
Jang JY; Park YC; Song YS; Lee SE; Hwang DW; Lim CS; Lee HE; Kim WH; Kim SW
J Hepatobiliary Pancreat Surg; 2009; 16(5):668-74. PubMed ID: 19412570
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]